SecBot SecBot
144 ·Filed Oct 20, 2026

KMTS

KESTRA MEDICAL TECHNOLOGIES, LTD.
NEUTRAL
Impact 3/10
Horizondays Processed6d 14h ago SEC0001964306-26-000472
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine equity monetization by an insider following a vesting event. The filing does not specify a sale date, and the insider may choose not to execute. Monitor for a subsequent Form 4 filing to confirm whether the sale was completed, and track any pattern of repeated sales by this insider.

DirectionNeutral
Confidencemedium
Horizondays
Latest settled — T+1d ⚠ clustered
KMTS ▲ +3.70% at T+1d
NEUTRAL call +3.70% · α vs SPY +4.88% · entry $27.31 → $28.32
Next anchor: T+5d in 2h
Latest observation: T+2 +4.96% FF3 residual α
Entry = T+0 close
Oct 20, 2026
via day close
T+1d
+3.70%
call +3.70% · α +4.88%
$28.32
settled 6d ago
T+5d
Pending
in 2h
T+20d
Pending
in 21d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Brian Daniel Webster, an officer and director of Kestra Medical Technologies, filed a Form 144 notice of intent to sell 15,000 common shares with an approximate market value of $443,389. The shares were originally granted as performance stock on July 14, 2026, under the company's equity compensation plan. This filing signals insider intent to monetize vested equity, though the sale may not ultimately occur.

Key Facts

  • Insider Brian Daniel Webster (Officer and Director) filed Form 144 to sell 15,000 shares of common stock.
  • Estimated market value of proposed sale: $443,388.63 based on a price of approximately $29.56 per share.
  • Shares were originally granted on July 14, 2026 as a performance stock issuance under the company's equity compensation plan.
  • Broker for the proposed sale is Merrill Lynch, located at 225 Liberty St, New York, NY.
  • The filing date is October 20, 2026; the shares have been held since July 14, 2026 (over 3 months).
  • Webster has a history of receiving equity grants and holding shares, as indicated by multiple prior acquisitions listed in the filing (totaling over 115,000 shares acquired between July and August 2026).

Financial Impact

Proposed sale of 15,000 shares valued at approximately $443,389, representing a modest portion of the insider's apparent holdings.

dilutioninsider holdings

Risk Factors

  • Insider selling, if executed, could signal reduced conviction or a need for liquidity, though this appears to be a routine post-vesting sale.
  • The filing does not disclose the exact number of shares the insider will retain post-sale, limiting assessment of proportional impact.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001964306-26-000472
Document: 0001964306-26-000472-index.html0001964306-26-000472
Document: 0001964306-26-000472.txt0001964306-26-000472
18 reports for KMTS
Performance horizon
100% Hit rate @ T+20 4 of 4 directional calls Went positive at some point 4 of 5 best @ T+20▲ +15.82%Aug 11, 2026
Filters
Rows
Reports for KMTS — sortable, filterable
TypeNow
Oct 22, 2026
5d ago
Insider Cluster
NEUTRAL ★ 3/10
$28.76awaiting T+20—$29.42 (+2.29%)
Oct 20, 2026
6d ago
144
NEUTRAL ★ 3/10
$27.31awaiting T+20—$29.42 (+7.73%)
Oct 20, 2026
6d ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$28.28awaiting T+20—$29.42 (+4.03%)
Sep 30, 2026
26d ago
144
NEUTRAL ★ 2/10
$27.12awaiting T+20—$29.42 (+8.50%)
Sep 14, 2026
6w ago
Press Release
MIXED ★ 6/10
$25.18 $26.97▲ +7.11%▲ +4.39%$29.42 (+16.84%)
Sep 10, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$22.85 $26.98▲ +18.07%▲ +16.21%$29.42 (+28.75%)
Sep 10, 2026
6w ago
Press Release
NEUTRAL ★ 2/10
$23.57 $25.77▲ +9.33%▲ +7.21%$29.42 (+24.82%)
Aug 31, 2026
8w ago
Press Release
NEUTRAL ★ 1/10
$25.12 $28.29▲ +12.62%▲ +12.30%$29.42 (+17.12%)
Aug 26, 2026
8w ago
Press Release
NEUTRAL ★ 3/10
$26.57 $25.76▼ −3.05%▼ −3.27%$29.42 (+10.73%)
Aug 11, 2026
10w ago
Insider Cluster
BEARISH ★ 5/10
$28.00 $23.57▲ +15.82%▲ +13.92%$29.42 (−5.07%)
Showing 10 of 18

US Market Status

Market Closed — Opens in 3h 11m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 20, 2026